In adults with asthma, when the IgE levels are very high (>700 IU/mL) as in this patient (1404 IU/mL), omalizumab is usually not recommended as there is insufficient data to recommend a dose.7 Subsequently, the patient reported a significant improvement in his condition with no notable side effects. This evidence concerns the gene IGHE and asthma.